The iconic diet company WeightWatchers has filed for Chapter 11 bankruptcy in the U.S., seeking to restructure nearly $1.15 billion in debt while vowing to continue operations uninterrupted.
The 62-year-old weight management brand, which once dominated the diet industry with its signature group meetings and point-based food tracking system, has struggled to adapt to a market increasingly dominated by injectable weight-loss medications such as Ozempic, Wegovy, and Zepbound.
WeightWatchers CEO Tara Comonte acknowledged the company faces a “rapidly changing weight management landscape,” referring to the explosive popularity of GLP-1 receptor agonist drugs that have revolutionised obesity treatment.
While the company now offers prescription weight-loss medications through its clinical division—which saw revenues jump 57% in early 2025—its core subscription business continues to decline, with membership revenues falling 9.3% year-on-year. The company reported a staggering $346 million net loss in 2024.
The bankruptcy filing, which has lender support, will allow WeightWatchers to eliminate decades-old debt while maintaining all current services, including its digital platform, telehealth offerings, and in-person workshops.
Comonte emphasised the brand’s resilience, stating, “For more than 62 years, WeightWatchers has empowered millions of members… staying resilient as trends have come and gone.” The company expects to complete restructuring within 40 days and emerge as a reorganised public entity.
Founded in 1963 as a modest support group for 400 members, WeightWatchers grew into a global phenomenon with its community-based approach to weight management. Its 2018 rebranding to “WW” reflected a pivot towards holistic wellness, but the company has struggled to compete with the dramatic results offered by new pharmaceutical options.
Comonte recently positioned WeightWatchers as a solution for maintaining weight after discontinuing medications, telling investors in February the company was navigating “a period of significant transition.”
With $1.88 billion in liabilities outweighing its assets, the bankruptcy marks a pivotal moment for the diet industry pioneer.
As WeightWatchers attempts to reinvent itself for the GLP-1 era, its journey reflects the profound shifts in how society approaches weight loss—from group accountability to clinical interventions. The company insists this is not the end, promising customers it’s “here to stay” despite the financial reckoning.
